Hasil Pencarian - Sarah Croessmann

  • Menampilkan 1 - 4 hasil dari 4
Perbaiki Hasil
  1. 1
    Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations

    Genomic dissection and mutation-specific target discovery for breast cancer PIK3CA hotspot mutations oleh Adam X. Miranda, Justin Kemp, Brad A. Davidson, Sara Erika Bellomo, Verda E. Miranda, Alexandra Manoni, Caterina Marchiò, Sarah Croessmann, Ben H. Park, Emily Hodges

    Diterbitkan 2024-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release

    An in vitro CRISPR screen of cell-free DNA identifies apoptosis as the primary mediator of cell-free DNA release oleh Brad. A. Davidson, Adam X. Miranda, Sarah C. Reed, Riley E. Bergman, Justin D. J. Kemp, Anvith P. Reddy, Morgan V. Pantone, Ethan K. Fox, R. Dixon Dorand, Paula J. Hurley, Sarah Croessmann, Ben Ho Park

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

    Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease oleh Hong Yuen Wong, Quanhu Sheng, Amanda B. Hesterberg, Sarah Croessmann, Brenda L. Rios, Khem Giri, Jorgen Jackson, Adam X. Miranda, Evan Watkins, Kerry R. Schaffer, Meredith Donahue, Elizabeth Winkler, David F. Penson, Joseph A. Smith, S. Duke Herrell, Amy N. Luckenbaugh, Daniel A. Barocas, Young J. Kim, Diana Graves, Giovanna A. Giannico, Jeffrey C. Rathmell, Ben H. Park, Jennifer B. Gordetsky, Paula J. Hurley

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

    Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer oleh Luigi Formisano, Yao Lu, Alberto Servetto, Ariella B. Hanker, Valerie M. Jansen, Joshua A. Bauer, Dhivya R. Sudhan, Angel L. Guerrero-Zotano, Sarah Croessmann, Yan Guo, Paula Gonzalez Ericsson, Kyung-min Lee, Mellissa J. Nixon, Luis J. Schwarz, Melinda E. Sanders, Teresa C. Dugger, Marcelo Rocha Cruz, Amir Behdad, Massimo Cristofanilli, Aditya Bardia, Joyce O’Shaughnessy, Rebecca J. Nagy, Richard B. Lanman, Nadia Solovieff, Wei He, Michelle Miller, Fei Su, Yu Shyr, Ingrid A. Mayer, Justin M. Balko, Carlos L. Arteaga

    Diterbitkan 2019-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: